格隆汇9月10日｜国海证券研报指出，中国化学上半年实现归属于上市公司股东的净利润31.02亿元，同 比增长9.26%；Q2实现归母净利润16.57亿元，同比+2.12%，环比+14.67%。二季度业绩稳中有增，公允 价值变动净收益同比增加、信用减值损失同比减少。2025年上半年，公司新签合同额2060.92亿元，较 上年同期增长25.23亿元，增幅1.24%。公司主业优势持续巩固，化学工程领域新签合同额首次上半年突 破1600亿元，深入实施"T+EPC"模式，成功中标多个重大项目，合同额近1000亿元。中国化学实业板块 坚持"创新驱动"战略，以高端化学品与先进材料为核心，深化"T+EPC"一体化模式（技术研发+工程总 承包），聚焦高性能纤维、可降解材料、气凝胶等化工新材料领域，突破"卡脖子"技术，推动产业向高 附加值方向升级。公司是化学工程龙头企业，实业项目开启第二成长曲线，维持"买入"评级。 ...

Group 1 - The company's net profit attributable to shareholders for H1 2025 increased by 9.26% year-on-year, aligning with expectations [1] - Total revenue for H1 2025 was 90.72 billion, a slight decrease of 0.35% year-on-year, while the net profit was 3.1 billion [1] - The company plans to distribute a cash dividend of 1.00 yuan per 10 shares, marking its first interim dividend [1] Group 2 - The chemical engineering segment reported revenue of 74.8 billion, up 1.21% year-on-year, with a gross margin increase of 0.3 percentage points to 10.2% [2] - The infrastructure segment saw a revenue decline of 10.0% year-on-year, totaling 9.11 billion, but with a gross margin increase of 1.3 percentage points to 7.1% [2] - Domestic revenue was 63.5 billion, down 8.9% year-on-year, while international revenue increased by 28.8% to 26.6 billion [2] Group 3 - The company's operating cash flow for H1 2025 was -10.03 billion, with a year-on-year increase in cash outflow of 5.46 billion [3] - The company is focusing on high-end chemicals and advanced materials, aiming to establish a second growth curve through innovative projects [3] - Profit forecasts for 2025-2027 are maintained at 5.99 billion, 6.59 billion, and 7.12 billion respectively, with corresponding PE ratios of 8X for 2025 and 2026, and 7X for 2027 [3]